Hainan Poly Pharm: Currently under investigation by the Securities Regulatory Commission. There is a risk of being subjected to compulsory delisting due to major illegal activities involving stocks.
Pharmaron's major shareholder, Xinchong Kangcheng, and his concerted actors completed a shareholding reduction of 16 million shares; two shareholders of Zhixin Precision intend to collectively reduce their shares by no more than 3.0375%; shareholders of Shenzhen SDG Service, Yinkun Company and Longxin Construction intend to collectively reduce their shares by no more than 2%; Wuxi Zhenhua's shareholder Wuxi Jinfengyu intends to reduce his shares by 3%; Hainan Poly Pharm is under investigation by the Securities Regulatory Commission due to risks of being subject to significant illegal delisting of stocks; Zhejiang Yiming Food's stocks have been涨停 for 10 consecutive trading days, posing a risk of a sharp decline in the short term; Tibet Summit Resources received a warning letter from the Tibet Securities Regulatory Bureau.
